| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 21.094 | 23.769 | 16.830 | 14.474 | 12.161 | 11.396 | 20.921 | 16.897 | 3.137 | 8.309 |
| Total Income - EUR | 21.095 | 23.771 | 16.830 | 14.474 | 12.161 | 11.396 | 20.921 | 16.897 | 3.137 | 8.309 |
| Total Expenses - EUR | 17.238 | 35.862 | 14.460 | 7.408 | 8.107 | 9.755 | 12.138 | 16.071 | 12.337 | 11.206 |
| Gross Profit/Loss - EUR | 3.857 | -12.092 | 2.370 | 7.067 | 4.055 | 1.641 | 8.783 | 826 | -9.201 | -2.898 |
| Net Profit/Loss - EUR | 3.067 | -12.092 | 1.865 | 6.632 | 3.690 | 1.305 | 8.236 | 395 | -9.201 | -2.898 |
| Employees | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Primary Health Development - Phd Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 17.804 | 9.986 | 2.887 | 0 | 0 | 392 | 213 | 43 | 0 | 0 |
| Current Assets | 2.820 | 6.402 | 16.716 | 22.563 | 15.133 | 15.176 | 19.641 | 18.869 | 11.194 | 5.606 |
| Inventories | 0 | 0 | 20 | 0 | 0 | 0 | 0 | 6 | 12 | 0 |
| Receivables | 1.440 | 4.004 | 13.566 | 12.680 | 3.074 | 3.115 | 3.059 | 5.476 | 3.063 | 3.033 |
| Cash | 1.380 | 2.398 | 3.130 | 9.883 | 12.059 | 12.061 | 16.582 | 13.387 | 8.118 | 2.573 |
| Shareholders Funds | 6.792 | -5.369 | -3.412 | 3.283 | 6.909 | 8.083 | 16.140 | 16.585 | 7.334 | 4.395 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 13.831 | 21.756 | 23.015 | 19.281 | 8.224 | 7.485 | 3.715 | 2.327 | 4.385 | 1.733 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Primary Health Development - Phd Srl